Results for regulatory data
How plausible may be a conference on IP (and regulatory) exclusivity? Sufficiently How plausible may be a conference on IP (and regulatory) exclusivity? Sufficiently Reviewed by Gabriele Girardello on Monday, November 14, 2022 Rating: 5
Conference report: Innovation and Competition in Life Sciences Law - Part I Conference report: Innovation and Competition in Life Sciences Law - Part I Reviewed by Mark Schweizer on Monday, June 12, 2017 Rating: 5
Shall we dance? Regulatory approval, trade secrets and the transatlantic biosimilars patent wars Shall we dance?  Regulatory approval, trade secrets and the transatlantic biosimilars patent wars Reviewed by Annsley Merelle Ward on Sunday, March 12, 2017 Rating: 5
Does the economic impact of SPCs necessitate SPC Regulation reform? The European Commission wants to find out Does the economic impact of SPCs necessitate SPC Regulation reform?  The European Commission wants to find out  Reviewed by Annsley Merelle Ward on Thursday, January 19, 2017 Rating: 5
AIPPI Congress Report 3: Biosimilars - into the great unknown? AIPPI Congress Report 3:  Biosimilars - into the great unknown? Reviewed by Annsley Merelle Ward on Wednesday, September 17, 2014 Rating: 5

More to read ...

More to read ... The IPKat has received copies of two more publications emanating from the Intellectual Property Institute . Although both w...
- Sunday, January 28, 2007
More to read ... More to read ... Reviewed by Jeremy on Sunday, January 28, 2007 Rating: 5
Powered by Blogger.